Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-09 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +38,000 38,000
2026-06-09 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +38,000 38,000
2026-04-21 BAKER BROS. ADVISORS LP Director Purchase · Warrants to purchase Common Stock +114,601 $4.44 $509K 1,678,273
2026-04-21 BAKER BROS. ADVISORS LP Director Purchase · Warrants to purchase Common Stock +2,137,651 $4.44 $9.5M 20,105,994
2025-06-12 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +76,000 76,000
2025-06-12 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +76,000 76,000
2024-06-14 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +23,500 23,500
2024-06-14 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +23,500 23,500
2023-12-13 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +593,452 $3.15 $1.9M 1,563,672
2023-12-13 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +7,343,307 $3.15 $23.1M 17,968,343
2023-06-16 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +23,500 23,500
2023-06-16 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +23,500 23,500
2023-05-22 BAKER BROS. ADVISORS LP Director Grant or award · Prelude Non-Voting Common Stock +121,178 $5.75 $697K 630,658
2023-05-22 BAKER BROS. ADVISORS LP Director Grant or award · Prelude Non-Voting Common Stock +1,327,044 $5.75 $7.6M 6,539,415
2023-05-22 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +970,220 $5.75 $5.6M 970,220
2023-05-22 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +10,625,036 $5.75 $61.1M 10,625,036
2022-06-17 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Options (right to buy) +34,300 34,300
2021-06-18 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Options (right to buy) +23,344 23,344
2021-01-27 BAKER BROS. ADVISORS LP Director Option exercise +5,188 $12.85 $67K 876,061
2021-01-27 BAKER BROS. ADVISORS LP Director Option exercise +5,188 $12.85 $67K 9,252,951

Page 1 of 3 · 55 trades